Robust, reproducible and quantitative analysis of thousands of proteomes by micro-flow LC-MS/MS.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
09 01 2020
Historique:
received: 14 09 2019
accepted: 10 12 2019
entrez: 11 1 2020
pubmed: 11 1 2020
medline: 25 3 2020
Statut: epublish

Résumé

Nano-flow liquid chromatography tandem mass spectrometry (nano-flow LC-MS/MS) is the mainstay in proteome research because of its excellent sensitivity but often comes at the expense of robustness. Here we show that micro-flow LC-MS/MS using a 1 × 150 mm column shows excellent reproducibility of chromatographic retention time (<0.3% coefficient of variation, CV) and protein quantification (<7.5% CV) using data from >2000 samples of human cell lines, tissues and body fluids. Deep proteome analysis identifies >9000 proteins and >120,000 peptides in 16 h and sample multiplexing using tandem mass tags increases throughput to 11 proteomes in 16 h. The system identifies >30,000 phosphopeptides in 12 h and protein-protein or protein-drug interaction experiments can be analyzed in 20 min per sample. We show that the same column can be used to analyze >7500 samples without apparent loss of performance. This study demonstrates that micro-flow LC-MS/MS is suitable for a broad range of proteomic applications.

Identifiants

pubmed: 31919466
doi: 10.1038/s41467-019-13973-x
pii: 10.1038/s41467-019-13973-x
pmc: PMC6952431
doi:

Substances chimiques

Peptides 0
Proteome 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

157

Subventions

Organisme : CIHR
ID : CIHR FDN 143301
Pays : Canada

Références

Circ Cardiovasc Genet. 2017 Dec;10(6):
pubmed: 29237681
J Proteome Res. 2009 Dec;8(12):5674-8
pubmed: 19848406
Proteomics. 2017 Apr;17(7):
pubmed: 27688154
Mol Cell Proteomics. 2015 Jul;14(7):1781-95
pubmed: 25900982
ACS Chem Biol. 2019 Apr 19;14(4):655-664
pubmed: 30901187
Mol Cell Proteomics. 2018 Dec;17(12):2534-2545
pubmed: 30385480
Mol Cell Proteomics. 2019 Jun;18(6):1242-1254
pubmed: 30948622
Nat Protoc. 2017 Jul;12(7):1289-1294
pubmed: 28569762
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
Nat Methods. 2013 Oct;10(10):989-91
pubmed: 23975139
Nat Methods. 2012 May 30;9(6):555-66
pubmed: 22669653
J Proteome Res. 2014 Dec 5;13(12):6169-75
pubmed: 25277625
Nat Methods. 2011 Jan;8(1):70-3
pubmed: 21131968
Anal Chem. 2018 Feb 6;90(3):2333-2340
pubmed: 29272103
Chem Soc Rev. 2012 May 21;41(10):3912-28
pubmed: 22498958
Mol Syst Biol. 2019 Mar 1;15(3):e8793
pubmed: 30824564
Nat Methods. 2015 Mar;12(3):258-64, 7 p following 264
pubmed: 25599550
Mol Syst Biol. 2017 Sep 26;13(9):942
pubmed: 28951502
Anal Chem. 2018 Apr 17;90(8):5381-5389
pubmed: 29582996
Mol Cell Proteomics. 2018 Nov;17(11):2284-2296
pubmed: 30104208
J Proteome Res. 2018 Jan 5;17(1):727-738
pubmed: 29183128
J Chromatogr A. 2019 Oct 11;1603:426-432
pubmed: 31301798
Anal Chem. 2018 Oct 2;90(19):11503-11508
pubmed: 30179449
Mol Cell. 2018 Feb 1;69(3):517-532.e11
pubmed: 29395067
J Proteomics. 2014 Apr 4;100:37-43
pubmed: 24513533
Front Bioeng Biotechnol. 2015 Apr 01;3:44
pubmed: 25883932
Crit Rev Anal Chem. 2016;46(2):93-105
pubmed: 25562585
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Mol Cell Proteomics. 2012 Jun;11(6):O111.016717
pubmed: 22261725
Proteomics. 2017 Nov;17(21):
pubmed: 28872757
Anal Chem. 2009 Jul 15;81(14):5955-60
pubmed: 19537771
Sci Rep. 2018 Mar 12;8(1):4346
pubmed: 29531254
Anal Chem. 2017 Sep 5;89(17):8884-8891
pubmed: 28759994
Anal Chem. 1996 Jan 1;68(1):1-8
pubmed: 8779426
Proteomics. 2017 Mar;17(6):
pubmed: 27538354
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243
Eur J Clin Chem Clin Biochem. 1992 May;30(5):311-7
pubmed: 1627730
Mol Cell Proteomics. 2019 Jul;18(7):1468-1478
pubmed: 30967486
Anal Chem. 2018 Aug 7;90(15):9529-9537
pubmed: 29969236
Methods Mol Biol. 2017;1550:115-136
pubmed: 28188527
Nat Biotechnol. 1999 Jul;17(7):676-82
pubmed: 10404161
Nat Methods. 2013 Dec;10(12):1239-45
pubmed: 24162924
Ann Clin Transl Neurol. 2019 Mar 07;6(4):698-707
pubmed: 31019994
Anal Biochem. 1998 Oct 1;263(1):93-101
pubmed: 9750149
Bioanalysis. 2015;7(14):1799-815
pubmed: 26270786
Methods. 2015 Jun 15;81:24-33
pubmed: 25858257
Mol Cell Proteomics. 2012 Nov;11(11):1475-88
pubmed: 22865924
Cell Syst. 2016 Oct 26;3(4):321-324
pubmed: 27788355
Science. 2017 Dec 1;358(6367):
pubmed: 29191878
Mol Cell Proteomics. 2015 Nov;14(11):3094-104
pubmed: 26342038

Auteurs

Yangyang Bian (Y)

Chair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.
Medical Research Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Runsheng Zheng (R)

Chair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.

Florian P Bayer (FP)

Chair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.

Cassandra Wong (C)

Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada.

Yun-Chien Chang (YC)

Chair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.

Chen Meng (C)

Bavarian Biomolecular Mass Spectrometry Center (BayBioMS), Technical University of Munich, Freising, Germany.

Daniel P Zolg (DP)

Chair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.

Maria Reinecke (M)

Chair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.
German Cancer Consortium (DKTK), partner site Munich, Munich, Germany.
German Cancer Research Center (DKFZ), Heidelberg, Germany.

Jana Zecha (J)

Chair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.

Svenja Wiechmann (S)

Chair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.
German Cancer Consortium (DKTK), partner site Munich, Munich, Germany.
German Cancer Research Center (DKFZ), Heidelberg, Germany.

Stephanie Heinzlmeir (S)

Chair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.

Johannes Scherr (J)

Centre for Preventive and Sports Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.

Bernhard Hemmer (B)

Department of Neurology, Klinikum Rechts der Isar, Medical Faculty, Technical University of Munich, Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.

Mike Baynham (M)

Thermo Fisher Scientific, Runcorn, UK.

Anne-Claude Gingras (AC)

Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada.

Oleksandr Boychenko (O)

Thermo Fisher Scientific, Germering, Germany.

Bernhard Kuster (B)

Chair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany. kuster@tum.de.
Bavarian Biomolecular Mass Spectrometry Center (BayBioMS), Technical University of Munich, Freising, Germany. kuster@tum.de.
German Cancer Consortium (DKTK), partner site Munich, Munich, Germany. kuster@tum.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH